- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00857012
Arimidex: Compliance and Arthralgias in Clinical Therapy (COMPACT) (COMPACT)
November 9, 2012 updated by: AstraZeneca
Arimidex: Compliance and Arthralgias in Clinical Therapy (COMPACT): An in Practice Assessment of Arthralgias and Related Costs as Well as Compliance in the First Year of Anastrozole Therapy
Patients are eligible for inclusion in this NIS if they have taken anastrozole either upfront or following two to three years of tamoxifen treatment ("switch") for at least three and not more than six months prior to offering an individual participation in this program.
Treatment should follow local therapy guidelines and standard practice.
Treatment decisions for patients participating in this study including assessments or supportive therapy during follow-up visits will also follow guidelines and remain independent of the program.
Study Overview
Status
Completed
Conditions
Detailed Description
The patient population will include postmenopausal women with hormone-receptor positive primary breast cancer scheduled for adjuvant upfront endocrine treatment with anastrozole or following two to three years of tamoxifen treatment ("switch") according to the current SmPC (Appendix C).
Patients will have taken anastrozole for at least three months and not more than six months before the start of the study.
Study Type
Observational
Enrollment (Actual)
2313
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aachen, Germany
- Research Site
-
Aalen, Germany
- Research Site
-
Ahaus, Germany
- Research Site
-
Albstadt, Germany
- Research Site
-
Altotting, Germany
- Research Site
-
Alzey, Germany
- Research Site
-
Amberg, Germany
- Research Site
-
Apolda, Germany
- Research Site
-
Aschaffenburg, Germany
- Research Site
-
Aschersleben, Germany
- Research Site
-
Augsburg, Germany
- Research Site
-
Aurich, Germany
- Research Site
-
Babenhausen, Germany
- Research Site
-
Bad Durkheim, Germany
- Research Site
-
Bad Herrenalb, Germany
- Research Site
-
Bad Nauheim, Germany
- Research Site
-
Bad Neuenahr-Ahrweiler, Germany
- Research Site
-
Bad Oeynhausen, Germany
- Research Site
-
Bad Oldesloe, Germany
- Research Site
-
Bad Reichenhall, Germany
- Research Site
-
Bad Saarow, Germany
- Research Site
-
Bad Segeberg, Germany
- Research Site
-
Bad Tolz, Germany
- Research Site
-
Bad Urach, Germany
- Research Site
-
Bad Wildbad, Germany
- Research Site
-
Bad Wildungen, Germany
- Research Site
-
Bad Windsheim, Germany
- Research Site
-
Baden-Baden, Germany
- Research Site
-
Bamberg, Germany
- Research Site
-
Bautzen, Germany
- Research Site
-
Bayreuth, Germany
- Research Site
-
Berlin, Germany
- Research Site
-
Berlin-Kreuzberg, Germany
- Research Site
-
Berlin-Steglitz, Germany
- Research Site
-
Bexbach, Germany
- Research Site
-
Biberach, Germany
- Research Site
-
Biedenkopf, Germany
- Research Site
-
Bielefeld, Germany
- Research Site
-
Bietigheim-Bissingen, Germany
- Research Site
-
Blankenburg, Germany
- Research Site
-
Blumberg in Baden, Germany
- Research Site
-
Boblingen, Germany
- Research Site
-
Bocholt, Germany
- Research Site
-
Bochum, Germany
- Research Site
-
Bonn, Germany
- Research Site
-
Borna, Germany
- Research Site
-
Bottrop, Germany
- Research Site
-
Brackenheim, Germany
- Research Site
-
Bramsche, Germany
- Research Site
-
Brandenburg, Germany
- Research Site
-
Braunschweig, Germany
- Research Site
-
Bretten, Germany
- Research Site
-
Bruchsal, Germany
- Research Site
-
Bruhl, Germany
- Research Site
-
Buhl, Germany
- Research Site
-
Bunde, Germany
- Research Site
-
Burg, Germany
- Research Site
-
Burghausen, Germany
- Research Site
-
Celle, Germany
- Research Site
-
Chemnitz, Germany
- Research Site
-
Cloppenburg, Germany
- Research Site
-
Coburg, Germany
- Research Site
-
Coesfeld, Germany
- Research Site
-
Dachau, Germany
- Research Site
-
Damme, Germany
- Research Site
-
Datteln, Germany
- Research Site
-
Demmin, Germany
- Research Site
-
Dessau, Germany
- Research Site
-
Dessau-Rosslau, Germany
- Research Site
-
Diessen, Germany
- Research Site
-
Dillenburg, Germany
- Research Site
-
Dillingen, Germany
- Research Site
-
Dinkelsbuhl, Germany
- Research Site
-
Ditzingen, Germany
- Research Site
-
Doberlug-Kirchhain, Germany
- Research Site
-
Dornstadt, Germany
- Research Site
-
Dorsten, Germany
- Research Site
-
Dortmund, Germany
- Research Site
-
Dreieich, Germany
- Research Site
-
Dresden, Germany
- Research Site
-
Duisburg, Germany
- Research Site
-
Duren, Germany
- Research Site
-
Dusseldorf, Germany
- Research Site
-
Ebermannstadt, Germany
- Research Site
-
Ebersbach, Germany
- Research Site
-
Eggenfelden, Germany
- Research Site
-
Eisenach, Germany
- Research Site
-
Ellwangen, Germany
- Research Site
-
Elmshorn, Germany
- Research Site
-
Emmendingen, Germany
- Research Site
-
Erding, Germany
- Research Site
-
Erfurt, Germany
- Research Site
-
Ergolding, Germany
- Research Site
-
Erkelenz, Germany
- Research Site
-
Eschweiler, Germany
- Research Site
-
Esens, Germany
- Research Site
-
Essen, Germany
- Research Site
-
Ettlingen, Germany
- Research Site
-
Euskirchen, Germany
- Research Site
-
Eutin, Germany
- Research Site
-
Feuchtwangen, Germany
- Research Site
-
Flensburg, Germany
- Research Site
-
Frankenberg, Germany
- Research Site
-
Frankenthal, Germany
- Research Site
-
Frankfurt (Oder), Germany
- Research Site
-
Frechen, Germany
- Research Site
-
Freiburg, Germany
- Research Site
-
Freising, Germany
- Research Site
-
Freital, Germany
- Research Site
-
Freyung, Germany
- Research Site
-
Friedrichshafen, Germany
- Research Site
-
Fulda, Germany
- Research Site
-
Furstenfeldbruck, Germany
- Research Site
-
Furstenwalde, Germany
- Research Site
-
Furth, Germany
- Research Site
-
Garbsen, Germany
- Research Site
-
Geesthacht, Germany
- Research Site
-
Geilenkirchen, Germany
- Research Site
-
Gelsenkirchen, Germany
- Research Site
-
Georgsmarienhutte, Germany
- Research Site
-
Gera, Germany
- Research Site
-
Geretsried, Germany
- Research Site
-
Gerlingen, Germany
- Research Site
-
Gersthofen, Germany
- Research Site
-
Giesen, Germany
- Research Site
-
Gifhorn, Germany
- Research Site
-
Gladbeck, Germany
- Research Site
-
Goppingen, Germany
- Research Site
-
Goslar, Germany
- Research Site
-
Gottingen, Germany
- Research Site
-
Grafelfing, Germany
- Research Site
-
Griesheim, Germany
- Research Site
-
Gummersbach, Germany
- Research Site
-
Gunzburg, Germany
- Research Site
-
Gustrow, Germany
- Research Site
-
Haiger, Germany
- Research Site
-
Halberstadt, Germany
- Research Site
-
Halle, Germany
- Research Site
-
Halle / Saale, Germany
- Research Site
-
Hamburg, Germany
- Research Site
-
Hameln, Germany
- Research Site
-
Hamm, Germany
- Research Site
-
Hannover, Germany
- Research Site
-
Hartha, Germany
- Research Site
-
Heide, Germany
- Research Site
-
Heidelberg, Germany
- Research Site
-
Heidenheim, Germany
- Research Site
-
Heilbronn, Germany
- Research Site
-
Heinsberg, Germany
- Research Site
-
Hemmingen, Germany
- Research Site
-
Henstedt-Ulzburg, Germany
- Research Site
-
Heppenheim, Germany
- Research Site
-
Herborn, Germany
- Research Site
-
Herbrechtingen, Germany
- Research Site
-
Herdecke, Germany
- Research Site
-
Herford, Germany
- Research Site
-
Hermsdorf, Germany
- Research Site
-
Herne, Germany
- Research Site
-
Herzberg, Germany
- Research Site
-
Herzberg am Harz, Germany
- Research Site
-
Hessisch Oldendorf, Germany
- Research Site
-
Hilchenbach, Germany
- Research Site
-
Hildesheim, Germany
- Research Site
-
Hillesheim, Germany
- Research Site
-
Hochstadt, Germany
- Research Site
-
Hof, Germany
- Research Site
-
Hofheim, Germany
- Research Site
-
Holzminden, Germany
- Research Site
-
Homburg/Saar, Germany
- Research Site
-
Huckelhoven, Germany
- Research Site
-
Ilsede, Germany
- Research Site
-
Ingolstadt, Germany
- Research Site
-
Isny, Germany
- Research Site
-
Itzehoe, Germany
- Research Site
-
Jena, Germany
- Research Site
-
Kahla, Germany
- Research Site
-
Kalkar, Germany
- Research Site
-
Karlsbad, Germany
- Research Site
-
Karlsruhe, Germany
- Research Site
-
Kassel, Germany
- Research Site
-
Kaufbeuren, Germany
- Research Site
-
Kempten, Germany
- Research Site
-
Kerpen, Germany
- Research Site
-
Kiel, Germany
- Research Site
-
Koblenz, Germany
- Research Site
-
Koln, Germany
- Research Site
-
Konigs Wusterhausen, Germany
- Research Site
-
Konstanz, Germany
- Research Site
-
Korntal-Munchingen, Germany
- Research Site
-
Krefeld, Germany
- Research Site
-
Kreuztal, Germany
- Research Site
-
Krumbach, Germany
- Research Site
-
Kunzelsau, Germany
- Research Site
-
Kusel, Germany
- Research Site
-
Laatzen, Germany
- Research Site
-
Lahnstein, Germany
- Research Site
-
Landau, Germany
- Research Site
-
Landshut, Germany
- Research Site
-
Langen, Germany
- Research Site
-
Langenhagen, Germany
- Research Site
-
Lauf, Germany
- Research Site
-
Lehrte, Germany
- Research Site
-
Leichlingen, Germany
- Research Site
-
Leipzig, Germany
- Research Site
-
Leisnig, Germany
- Research Site
-
Leonberg, Germany
- Research Site
-
Leverkusen, Germany
- Research Site
-
Lich, Germany
- Research Site
-
Limburg, Germany
- Research Site
-
Lingen, Germany
- Research Site
-
Lobau, Germany
- Research Site
-
Lohsa OT Weisskollm, Germany
- Research Site
-
Lubeck, Germany
- Research Site
-
Ludwigsfelde, Germany
- Research Site
-
Ludwigshafen, Germany
- Research Site
-
Luneburg, Germany
- Research Site
-
Lunen, Germany
- Research Site
-
Magdeburg, Germany
- Research Site
-
Mannheim, Germany
- Research Site
-
Marburg, Germany
- Research Site
-
Marienheide, Germany
- Research Site
-
Markranstadt, Germany
- Research Site
-
Marktredwitz, Germany
- Research Site
-
Marl, Germany
- Research Site
-
Mayen, Germany
- Research Site
-
Meiningen, Germany
- Research Site
-
Meissen, Germany
- Research Site
-
Memmingen, Germany
- Research Site
-
Mendig, Germany
- Research Site
-
Mettingen, Germany
- Research Site
-
Metzingen, Germany
- Research Site
-
Minden, Germany
- Research Site
-
Mittweida, Germany
- Research Site
-
Moers, Germany
- Research Site
-
Monchengladbach, Germany
- Research Site
-
Muhldorf, Germany
- Research Site
-
Muhlhausen, Germany
- Research Site
-
Muhlheim, Germany
- Research Site
-
Mulheim a. d. Ruhr, Germany
- Research Site
-
Munchen, Germany
- Research Site
-
Munster, Germany
- Research Site
-
Mutlangen, Germany
- Research Site
-
Nauen, Germany
- Research Site
-
Naunhof, Germany
- Research Site
-
Neckarsulm, Germany
- Research Site
-
Netphen, Germany
- Research Site
-
Neubrandenburg, Germany
- Research Site
-
Neuhaus am Rennweg, Germany
- Research Site
-
Neumarkt, Germany
- Research Site
-
Neumunster, Germany
- Research Site
-
Neuruppin, Germany
- Research Site
-
Neustadt, Germany
- Research Site
-
Neustadt an der Weinstrasse, Germany
- Research Site
-
Nienburg, Germany
- Research Site
-
Nordhausen, Germany
- Research Site
-
Nordhorn, Germany
- Research Site
-
Numbrecht, Germany
- Research Site
-
Nurnberg, Germany
- Research Site
-
Nurtingen, Germany
- Research Site
-
Oberhausen, Germany
- Research Site
-
Oberstdorf, Germany
- Research Site
-
Ochsenfurt, Germany
- Research Site
-
Offenbach, Germany
- Research Site
-
Offenburg, Germany
- Research Site
-
Oranienburg, Germany
- Research Site
-
Osnabruck, Germany
- Research Site
-
Paderborn, Germany
- Research Site
-
Parchim, Germany
- Research Site
-
Passau, Germany
- Research Site
-
Peine, Germany
- Research Site
-
Penzberg, Germany
- Research Site
-
Pfinztal, Germany
- Research Site
-
Pforzheim, Germany
- Research Site
-
Pfullingen, Germany
- Research Site
-
Pinneberg, Germany
- Research Site
-
Pirmasens, Germany
- Research Site
-
Plauen-Kauschwitz, Germany
- Research Site
-
Pocking, Germany
- Research Site
-
Potsdam, Germany
- Research Site
-
Quickborn, Germany
- Research Site
-
Rahden, Germany
- Research Site
-
Rangsdorf, Germany
- Research Site
-
Ravensburg, Germany
- Research Site
-
Recklinghausen, Germany
- Research Site
-
Regensburg, Germany
- Research Site
-
Reinbek, Germany
- Research Site
-
Remchingen, Germany
- Research Site
-
Remscheid, Germany
- Research Site
-
Rendsburg, Germany
- Research Site
-
Reutlingen, Germany
- Research Site
-
Rheine, Germany
- Research Site
-
Rheinfelden, Germany
- Research Site
-
Riebnitz-Damgarten, Germany
- Research Site
-
Riesa, Germany
- Research Site
-
Rodewisch, Germany
- Research Site
-
Rodgau, Germany
- Research Site
-
Rosenheim, Germany
- Research Site
-
Rosrath, Germany
- Research Site
-
Rotenburg, Germany
- Research Site
-
Rottenburg, Germany
- Research Site
-
Rottweil, Germany
- Research Site
-
Saarbrucken, Germany
- Research Site
-
Saarlouis, Germany
- Research Site
-
Salzgitter, Germany
- Research Site
-
Salzwedel, Germany
- Research Site
-
Sandhausen, Germany
- Research Site
-
Sayda, Germany
- Research Site
-
Schalksmuhle, Germany
- Research Site
-
Scheibenberg, Germany
- Research Site
-
Schkeuditz, Germany
- Research Site
-
Schleswig, Germany
- Research Site
-
Schonaich, Germany
- Research Site
-
Schonebeck, Germany
- Research Site
-
Schorndorf, Germany
- Research Site
-
Schwabach, Germany
- Research Site
-
Schwabisch Hall, Germany
- Research Site
-
Schwandorf, Germany
- Research Site
-
Schweinfurt, Germany
- Research Site
-
Schwerin, Germany
- Research Site
-
Schwerte, Germany
- Research Site
-
Schwetzingen, Germany
- Research Site
-
Sebnitz, Germany
- Research Site
-
Senden, Germany
- Research Site
-
Siegen, Germany
- Research Site
-
Simmern, Germany
- Research Site
-
Singen (Hohentwiel), Germany
- Research Site
-
Sogel, Germany
- Research Site
-
Solingen, Germany
- Research Site
-
Sommerda, Germany
- Research Site
-
Spremberg, Germany
- Research Site
-
Sprockhovel, Germany
- Research Site
-
St. Wendel, Germany
- Research Site
-
Starnberg, Germany
- Research Site
-
Stendal, Germany
- Research Site
-
Stockelsdorf, Germany
- Research Site
-
Stralsund, Germany
- Research Site
-
Stuhr, Germany
- Research Site
-
Stuttgart, Germany
- Research Site
-
Sulzbach-Rosenberg, Germany
- Research Site
-
Teltow, Germany
- Research Site
-
Tettnang, Germany
- Research Site
-
Torgau, Germany
- Research Site
-
Tornesch, Germany
- Research Site
-
Tubingen, Germany
- Research Site
-
Uelzen, Germany
- Research Site
-
Uetze, Germany
- Research Site
-
Ulm, Germany
- Research Site
-
Vechta, Germany
- Research Site
-
Vechta-Langforden, Germany
- Research Site
-
Veitshochheim, Germany
- Research Site
-
Viersen, Germany
- Research Site
-
Villingen-Schwenningen, Germany
- Research Site
-
Vilsbiburg, Germany
- Research Site
-
Vlotho, Germany
- Research Site
-
Vohringen, Germany
- Research Site
-
Volklingen, Germany
- Research Site
-
Waldmunchen, Germany
- Research Site
-
Walsrode, Germany
- Research Site
-
Wangen, Germany
- Research Site
-
Warburg, Germany
- Research Site
-
Warendorf, Germany
- Research Site
-
Warin, Germany
- Research Site
-
Wasserburg, Germany
- Research Site
-
Weiden in der Oberpfalz, Germany
- Research Site
-
Weingarten, Germany
- Research Site
-
Wermelskirchen, Germany
- Research Site
-
Werneck, Germany
- Research Site
-
Wertheim, Germany
- Research Site
-
Wetzlar, Germany
- Research Site
-
Wiesbaden, Germany
- Research Site
-
Wilster, Germany
- Research Site
-
Wismar, Germany
- Research Site
-
Witten, Germany
- Research Site
-
Witterda, Germany
- Research Site
-
Wolfen, Germany
- Research Site
-
Wolfsburg, Germany
- Research Site
-
Worms, Germany
- Research Site
-
Wuppertal, Germany
- Research Site
-
Wurselen, Germany
- Research Site
-
Wurzburg, Germany
- Research Site
-
Zittau, Germany
- Research Site
-
Zossen, Germany
- Research Site
-
Zwickau, Germany
- Research Site
-
Zwiesel, Germany
- Research Site
-
Zwonitz, Germany
- Research Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
The patient population will include postmenopausal women with hormone-receptor positive primary breast cancer receiving adjuvant endocrine treatment with anastrozole upfront or following two to three years of tamoxifen therapy ("switch") according to the current SmPC (Appendix C).
Patients will have received anastrozole treatment for at least 3 months and up to 6 months before the start of the study.
Description
Inclusion Criteria:
- Postmenopausal women aged 18 years or older; Postmenopause is defined as Natural menopause with menses >1 year ago or Serum FSH (> 20 IU/ l), and E2 levels in the postmenopausal range or patients who had bilateral oophorectomy
- Histologically / cytologically confirmed primary diagnosis of early breast cancer (M0) with hormone sensitive tumour (ER+ve and/or PgR+ve)
- Patients, who underwent breast cancer surgery and, if appl. radiation therapy and/or neo/adjuvant chemotherapy and have taken adjuvant endocrine treatment with anastrozole (upfront or following two to three years of tamoxifen) min 3 max 6 months
- In case of a previous therapy with tamoxifen (switch-therapy), duration of tamoxifen treatment for at least two and up to three years.
Exclusion Criteria:
- Patients with severe renal function disorders (Creatinine clearance < 20 ml/min or Patients with moderate or severe disorders of hepatic function
- Concomitant treatment with drugs known to affect sex hormonal status and tamoxifen
- Patients with ductal carcinoma in situ (DCIS) without primary diagnosis of early breast cancer (M0)
- Evidence of any significant clinical disorder or laboratory finding which in the opinion of the investigator, makes it undesirable for the patient to participate in the program
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
All patients
treated with Anastrozole as per SPC
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Assessment of arthralgia scores and patients' compliance within the first year of anastrozole treatment, stratified by upfront and switch therapy as well as assessment of the relationship between compliance and arthralgia scores.
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incidence of arthralgia and arthralgia characteristics within the 1st year of anastrozole therapy stratified by upfront and switch therapy and assessment of the relationship of arthralgia incidence and arthralgia characteristics to patients compliance.
Time Frame: 12 months
|
12 months
|
|
Retrospective assessment of incidence of pre-existing arthralgias before start of anastrozole treatment, stratified by upfront and switch therapy.
Time Frame: 12 months
|
12 months
|
|
Descriptive assessment of arthralgia therapy and of costs of arthralgia therapy, stratified by upfront and switch therapy.
Time Frame: 12 months
|
12 months
|
|
Identification of factors influencing and correlating to treatment-emergent arthralgias
Time Frame: 12 months
|
12 months
|
|
Assessment of safety and tolerability of anastrozole.
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: H Brasch, AstraZeneca, Germany
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2009
Study Completion (Actual)
February 1, 2012
Study Registration Dates
First Submitted
March 5, 2009
First Submitted That Met QC Criteria
March 5, 2009
First Posted (Estimate)
March 6, 2009
Study Record Updates
Last Update Posted (Estimate)
November 12, 2012
Last Update Submitted That Met QC Criteria
November 9, 2012
Last Verified
November 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NIS-ODE-ARI-2008/1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
Oncoliq US IncRecruitingBreast Cancer Female | Breast Cancer Detection | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Breast Cancer With Low to Intermediate HER2 Expression | Breast Cancer - Female | Breast Cancer (Early Breast Cancer) | Breast Cancer - Ductal Carcinoma in Situ (DCIS) | Breast Cancer - Infiltrating...Argentina
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Joseph Baar, MD, PhDCompletedBreast Cancer | Stage I Breast Cancer | Inflammatory Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast CancerUnited States
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Case Comprehensive Cancer CenterNational Institute on Minority Health and Health Disparities (NIMHD)CompletedCancer Survivor | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States